Healthcare provider profile · identity verified

Laura Celeste Brenes, MD

General Practice · FARMINGTON, CT · NPI 1174795371

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Trazodone Hcl	Trazodone Hcl	534	88
Atorvastatin Calcium	Atorvastatin Calcium	514	113
Eliquis	Apixaban	434	46
Levothyroxine Sodium	Levothyroxine Sodium	344	64
Amlodipine Besylate	Amlodipine Besylate	340	75
Furosemide	Furosemide	317	51
Gabapentin	Gabapentin	251	54
Escitalopram Oxalate	Escitalopram Oxalate	238	46
Quetiapine Fumarate	Quetiapine Fumarate	236	25
Mirtazapine	Mirtazapine	225	43
Pantoprazole Sodium	Pantoprazole Sodium	224	50
Sertraline Hcl	Sertraline Hcl	213	37
Metoprolol Tartrate	Metoprolol Tartrate	176	34
Tamsulosin Hcl	Tamsulosin Hcl	174	32
Losartan Potassium	Losartan Potassium	155	35
Metformin Hcl	Metformin Hcl	142	34
Lisinopril	Lisinopril	140	39
Metoprolol Succinate	Metoprolol Succinate	138	34
Omeprazole	Omeprazole	130	26
Donepezil Hcl	Donepezil Hcl	111	17
Potassium Chloride	Potassium Chloride	110	22
Divalproex Sodium	Divalproex Sodium	103	26
Xarelto	Rivaroxaban	102	suppressed
Famotidine	Famotidine	96	25
Carvedilol	Carvedilol	93	22
Risperidone	Risperidone	79	19
Januvia	Sitagliptin Phosphate	73	suppressed
Duloxetine Hcl	Duloxetine Hcl	72	16
Lactulose	Lactulose	72	suppressed
Memantine Hcl	Memantine Hcl	72	12
Rosuvastatin Calcium	Rosuvastatin Calcium	68	30
Baclofen	Baclofen	66	suppressed
Latanoprost	Latanoprost	66	13
Buspirone Hcl	Buspirone Hcl	64	suppressed
Linzess	Linaclotide	64	suppressed
Finasteride	Finasteride	63	11
Allopurinol	Allopurinol	61	13
Montelukast Sodium	Montelukast Sodium	56	12
Carbidopa-Levodopa	Carbidopa/Levodopa	52	suppressed
Simvastatin	Simvastatin	51	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	suppressed
Citalopram Hbr	Citalopram Hydrobromide	48	suppressed
Levetiracetam	Levetiracetam	48	11
Prednisone	Prednisone	47	17
Alendronate Sodium	Alendronate Sodium	46	11
Jardiance	Empagliflozin	45	suppressed
Tradjenta	Linagliptin	43	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	41	32
Ezetimibe	Ezetimibe	40	suppressed
Fluticasone Propionate	Fluticasone Propionate	40	21
Spironolactone	Spironolactone	40	suppressed
Hydralazine Hcl	Hydralazine Hcl	39	suppressed
Lamotrigine	Lamotrigine	39	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Myrbetriq	Mirabegron	38	suppressed
Clopidogrel	Clopidogrel Bisulfate	36	11
Meloxicam	Meloxicam	36	12
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Olanzapine	Olanzapine	35	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	34	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	31	11
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Ingrezza	Valbenazine Tosylate	29	suppressed
Midodrine Hcl	Midodrine Hcl	29	suppressed
Benztropine Mesylate	Benztropine Mesylate	28	suppressed
Metformin Hcl Er	Metformin Hcl	28	suppressed
Ondansetron Odt	Ondansetron	28	suppressed
Torsemide	Torsemide	28	suppressed
Atenolol	Atenolol	27	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Memantine Hcl Er	Memantine Hcl	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	26	suppressed
Vraylar	Cariprazine Hcl	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Haloperidol	Haloperidol	25	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	25	suppressed
Topiramate	Topiramate	25	suppressed
Verapamil Sr	Verapamil Hcl	25	suppressed
Azithromycin	Azithromycin	24	20
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	13
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Oxcarbazepine	Oxcarbazepine	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	22	suppressed
Glycopyrrolate	Glycopyrrolate	22	suppressed
Hydrocortisone	Hydrocortisone	22	suppressed
Invokana	Canagliflozin	22	suppressed
Clozapine	Clozapine	21	suppressed
Incruse Ellipta	Umeclidinium Bromide	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Digoxin	Digoxin	20	suppressed
Insulin Aspart Flexpen	Insulin Aspart	20	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	20	13
Gemtesa	Vibegron	19	suppressed
Insulin Lispro	Insulin Lispro	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Ozempic	Semaglutide	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	12
Nifedipine Er	Nifedipine	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	15	14
Exemestane	Exemestane	15	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	15	suppressed
Sodium Chloride	0.9 % Sodium Chloride	15	suppressed
Travoprost	Travoprost	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Calcitriol	Calcitriol	14	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	14	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Minocycline Hcl	Minocycline Hcl	14	suppressed
Valsartan	Valsartan	14	suppressed
Lidocaine	Lidocaine	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Lurasidone Hcl	Lurasidone Hcl	13	suppressed
Mesalamine	Mesalamine	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	12	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Perphenazine	Perphenazine	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Dapagliflozin	Dapagliflozin Propanediol	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	11	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Rivastigmine	Rivastigmine Tartrate	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	11
Timolol Maleate	Timolol Maleate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error